CSBR
Champions Oncology, Inc.
CSBR trails on the overall score without a compensating advantage in the available component scores.
UNH
UnitedHealth Group Incorporated
UNH has the edge over CSBR overall, supported by stronger fundamentals and stronger modeled upside.
CSBR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Strong |
CSBR's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
CSBR PE Valuation
CSBR has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
CSBR Forward outlook
There aren't enough analyst estimates for CSBR to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CSBR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.08 | -138% |
| Q2 2026 | -$0.08 | -124% |
| Q1 2026 | -$0.15 | -134% |
| Q4 2025 | $0.18 | +$0.24 |
| Q3 2025 | $0.21 | +$0.47 |
| Q2 2025 | $0.33 | +$0.87 |
| Q1 2025 | $0.44 | +$1.16 |
| Q4 2024 | -$0.06 | +$0.65 |
CSBR has swung to a loss: it lost $0.08 per share over the past year, after a profit the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over CSBR on earnings quality, reporting a profit while its opponent remains loss making.
CSBR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $15.2M | +8.8% |
| Q2 2026 | $13.8M | +12% |
| Q1 2026 | $16.6M | -2.8% |
| Q4 2025 | $15M | +11% |
| Q3 2025 | $14M | -0.5% |
| Q2 2025 | $12.4M | -12% |
| Q1 2025 | $17M | +42% |
| Q4 2024 | $13.5M | +17% |
CSBR's revenue is growing: $15M last quarter, up 8.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.7% | +1.1 points |
| Q2 2026 | -3.8% | +13 points |
| Q1 2026 | -1.7% | -28 points |
| Q4 2025 | 1.2% | -4.2 points |
| Q3 2025 | -3.8% | -13 points |
| Q2 2025 | -16% | -14 points |
| Q1 2025 | 26% | +48 points |
| Q4 2024 | 5.4% | +22 points |
CSBR's operating margin was −2.7% last quarter, up 1.1 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over CSBR on profitability, with a higher operating margin.
CSBR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$547K | -199% |
| Q2 2026 | -$2.2M | -134% |
| Q1 2026 | -$1.4M | -407% |
| Q4 2025 | -$2M | -$1.6M |
| Q3 2025 | $554K | +78% |
| Q2 2025 | $6.6M | +$8.3M |
| Q1 2025 | $448K | +$1.5M |
| Q4 2024 | -$377K | -186% |
CSBR's free cash flow was −$6M over the past year, against $7M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over CSBR on cash generation, producing positive trailing cash flow while its opponent burns cash.
CSBR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +65.2K shares |
| 1 year | +0.8% | +109K shares |
| 3 years | +2.9% | +391K shares |
| 5 years | +3.7% | +496K shares |
| Available history | +7.2% | +933K shares |
CSBR has 14M diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | $32,000 |
| Q3 2023 | $602,000 |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over CSBR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
CSBR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -15.0x | Net Cash |
| Q2 2026 | -22.6x | Net Cash |
| Q4 2025 | -2.3x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -3.3x | Net Cash |
| Q4 2022 | -5.2x | Net Cash |
CSBR has the edge over UNH on leverage, with a lower net debt burden relative to earnings.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
CSBR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.5 | Neutral |
| Stochastic | 11.5 | Oversold |
CSBR's weekly RSI is 37 (neutral) and its Stochastic is 11 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
CSBR PE vs Healthcare Sector
| Metric | CSBR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
CSBR has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
CSBR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.79 | 2.9% below |
| 20 week MA | $5.17 | 10% below |
| 50 week MA | $5.83 | 20% below |
| 100 week MA | $6.81 | 32% below |
| 200 week MA | $6.01 | 23% below |
CSBR is in a downtrend: it's below all five of its weekly moving averages, and 23% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over CSBR on trend strength, trading above more of its moving averages.
CSBR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.71 | $11.2 | +45% |
| 2021 | $11.2 | $8.04 | -28% |
| 2022 | $8.04 | $4.48 | -44% |
| 2023 | $4.48 | $5.62 | +25% |
| 2024 | $5.62 | $8.35 | +49% |
| 2025 | $8.35 | $6.98 | -16% |
| 2026 YTD | $6.98 | $4.65 | -33% |
CSBR has finished lower in three of the last six years. It's down 33% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over CSBR on returns for 2026, with the stronger performance.